Author: Oliver Holmes

Santen today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ryjunea® (low-dose atropine 0.1 mg/ml), the first licensed treatment in the UK to slow the progression of myopia in children.[3] The approval follows the European Commission authorisation and the first launch in Germany earlier this year, with additional launches in Europe to follow.[4,5]Read More

Read More

Dhananjai Lifestyle Ltd., a leading name in India’s fashion and lifestyle retail segment, recently announced that it has signed and executed a brand licensing agreement with Galaxy Universal, LLC to introduce the globally recognized apparel brand Cherokee® across India. The partnership enables DhanaRead More

Read More